You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 199 No. 6, February 6, 1967 TABLE OF CONTENTS
  JAMA
  •  Online Features
  PRELIMINARY COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevention of Rh Isoimmunization

Progress Report of the Clinical Trial in Mothers

Vincent J. Freda, MD; John G. Gorman, MB, BS; William Pollack, PhD; John G. Robertson, MD; Elmer R. Jennings, MD; John F. Sullivan, MD

JAMA. 1967;199(6):390-394.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Many workers have shown conclusively that passive antibody is capable of specific immunosuppression of the active immunity that follows injection of an antigen.1-18 It is also clear from experimental results in mice that specific IgG antibody is from 100 to 200 times more immunosuppressive than specific IgM antibody.18 No attempts had been made to apply this very real immunological phenomenon as a means of immunosuppression for a practical purpose until in 1960 three of the authors (V.J.F., J.G.G., and W.P.) began a program to explore the possibilities of using passive antibody to prevent Rh-negative mothers from becoming immunized by Rh-positive fetuses.19-29 Our specific hope that the method might work for Rh was supported by the implications of Levine's observations30 and by actual experimental data of Stern et al,31 that circulating anti-A and anti-B antibodies actually do prevent Rh-negative mothers from being sensitized to the Rh . . . [Full Text PDF of this Article]


Author Affiliations

From the departments of obstetrics and gynecology and pathology, Columbia University College of Physicians and Surgeons, and the Presbyterian Hospital, New York (Drs. Freda, Gorman, and Robertson); the Ortho Research Foundation, Raritan, NJ (Dr. Pollack); and the Pathology Department, Memorial Hospital of Long Beach, Long Beach, Calif (Drs. Jennings and Sullivan). Dr. Robertson was a Wellcome Trust Research Fellow at Columbia University College of Physicians and Surgeons. He is now with the Department of Obstetrics and Gynecology, University of Edinburg, Edinburg, Scotland. Dr. Sullivan is now with the Department of Pathology, St. Elizabeth's Hospital, Appleton, Wis.


Footnotes

Reprint requests to 630 W 168th St, New York 10032 (Dr. Freda).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.